Skip to content
PfizerPfizerPfizerJKIJKIJKI101010

Drawing based on the label description. No photo yet.

“10 mg of tofacitinib: Blue, round, immediate-release film-coated tablets, debossed with "Pfizer" on one side, and "JKI 10" on the other side”

PFIZER JKI10 pill

Pill with imprint PFIZER JKI10 is blue, round, 10 mm and has been identified as Tofacitinib 10 mg. It is used for rheumatoid arthritis. It is supplied by Pfizer Laboratories Div Pfizer Inc.

Tofacitinib 10 mg

Imprint
PFIZER JKI10
Strength
10 mg
Used for
Rheumatoid arthritis
Color
Blue
Shape
Round
Size
10 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Pfizer Laboratories Div Pfizer Inc
Drug class
Cancer medicine (kinase inhibitor)
NDC
0069-1002, 0069-1002-01

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Tofacitinib pills and guides

What is Tofacitinib used for?

Tofacitinib is used for rheumatoid arthritis.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Rheumatoid Arthritis

Tofacitinib extended-release tablets are indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA), who have had an inadequate response or intolerance to one or more TNF blockers.

Limitations of Use

Use of tofacitinib extended-release tablets in combination with biologic disease-modifying antirheumatic drugs (DMARDs) or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended.

Psoriatic Arthritis

Tofacitinib extended-release tablets are indicated for the treatment of adults with active PsA who have had an inadequate response or intolerance to one or more TNF blockers.

Limitations of Use

Use of tofacitinib extended-release tablets in combination with biologic DMARDs or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended.

Ankylosing Spondylitis

Tofacitinib extended-release tablets are indicated for the treatment of adult patients with active ankylosing spondylitis (AS), who have had an inadequate response or intolerance to one or more TNF blockers.

Limitations of Use

Use of tofacitinib extended-release tablets in combination with biologic DMARDs or potent immunosuppressants such as azathioprine and cyclosporine is not recommended.

From the FDA-approved label on DailyMed (published Oct 05, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows Pfizer and the other side shows JKI 10.
  • It is blue, round, 10 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Xeljanz.

Ingredients

Active: Tofacitinib Citrate

Inactive: Microcrystalline Cellulose, Lactose Monohydrate, Croscarmellose Sodium, Magnesium Stearate, Titanium Dioxide, Triacetin, Polyethylene Glycol 3350, Hypromellose 2910 (6 Mpa.s), Fd&c Blue No. 1, Fd&c Blue No. 2

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Tofacitinib pills